Creon 120000 [USP'U]/1

Creon 120000 [USP'U]/1 is a pancreatic enzyme replacement therapy designed to aid digestion in individuals with exocrine pancreatic insufficiency. This delayed-release capsule helps break down fats, proteins, and carbohydrates for better nutrient absorption.

Creon 120000 [USP'U]/1 is primarily used to manage digestive issues in conditions like cystic fibrosis and chronic pancreatitis. It contains pancrelipase, which helps the body digest fats, proteins, and carbohydrates more effectively. This medication is often prescribed for individuals who struggle with nutrient absorption due to pancreatic insufficiency.

Common effects of Creon 120000 [USP'U]/1 may include improved digestion and reduced symptoms like bloating, gas, and diarrhea. Some users might experience mild stomach discomfort or changes in bowel movements. Always consult a healthcare provider for personalized advice.

Handle Creon 120000 [USP'U]/1 capsules carefully, ensuring they are swallowed whole to avoid irritation. Store the medication in a cool, dry place away from moisture. Follow the prescribed dosage and administration instructions provided by your healthcare provider.

Creon 120000 [USP'U]/1 may interact with certain medications, including antacids and some antibiotics. Always inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.